As of 2025-05-29, the Intrinsic Value of HBM Healthcare Investments AG (HBMN.SW) is 232.38 CHF. This HBMN.SW valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 172.60 CHF, the upside of HBM Healthcare Investments AG is 34.60%.
The range of the Intrinsic Value is 175.47 - 336.96 CHF
Based on its market price of 172.60 CHF and our intrinsic valuation, HBM Healthcare Investments AG (HBMN.SW) is undervalued by 34.60%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 175.47 - 336.96 | 232.38 | 34.6% |
| DCF (Growth 10y) | 669.63 - 1,361.01 | 911.79 | 428.3% |
| DCF (EBITDA 5y) | 100.16 - 157.52 | 125.21 | -27.5% |
| DCF (EBITDA 10y) | 426.94 - 699.40 | 542.54 | 214.3% |
| Fair Value | 66.60 - 66.60 | 66.60 | -61.41% |
| P/E | 28.45 - 95.03 | 58.35 | -66.2% |
| EV/EBITDA | (4.22) - 32.90 | 12.73 | -92.6% |
| EPV | (31.11) - (39.89) | (35.50) | -120.6% |
| DDM - Stable | 20.88 - 49.61 | 35.24 | -79.6% |
| DDM - Multi | 248.23 - 419.43 | 308.91 | 79.0% |
| Market Cap (mil) | 1,201.30 |
| Beta | 0.88 |
| Outstanding shares (mil) | 6.96 |
| Enterprise Value (mil) | 1,298.39 |
| Market risk premium | 5.10% |
| Cost of Equity | 7.38% |
| Cost of Debt | 4.25% |
| WACC | 7.09% |